UC Davis Health Tests the COVID-19 Antibody “Cocktail” Given to President Trump
In a new COVID-19 clinical trial, UC Davis Health tests the same REGN-COV2 antibody combination given to President Trump. In a new clinical trial, UC…
In a new COVID-19 clinical trial, UC Davis Health tests the same REGN-COV2 antibody combination given to President Trump. In a new clinical trial, UC…
In this study, which was recently published in the journal Frontiers in Immunology, researchers used sequencing to characterize the immune system of patients who survive…
One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how…
Scientists in the US and UK publish first in-depth look at how CD4+ T cells fight SARS-CoV-2. As scientists around the world develop life-saving COVID-19…
President Donald Trump’s announcement that he’d tested positive for COVID-19 was especially concerning because of his age. At 74 years old, Trump is solidly within…
Being previously infected with coronaviruses that cause the “common cold” may decrease the severity of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infections, according to the…
Patients of Black ethnicity have an increased risk of requiring hospital admission for COVID-19, while patients of Asian ethnicity have an increased risk of dying…
Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a new study published…
With 74-year-old President Trump and 50-year-old first lady Melania Trump testing positive for the coronavirus, what are the best proven treatments for them and other…
Research led by Texas A&M University Associate Professor Wonmuk Hwang has led to a better understanding of how components of the body’s immune system find…
Airway cell analyses showing an activated immune axis could pinpoint the COVID-19 patients who will most benefit from targeted therapies. KAIST researchers have identified key…
New platform technology uses red blood cells to generate targeted immune responses in mice. Red blood cells do more than shuttle oxygen from our lungs…
Seasonal colds are by all accounts no fun, but new research suggests the colds you’ve had in the past may provide some protection from COVID-19….
A cocktail of powerful antibodies identified in recovered patients locks the coronavirus infection machinery, inhibits SARS-CoV-2 attachment to host cells, and protects animals challenged with…
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité – Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are…
A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the development of an effective vaccine, according to a study published…
Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to…
Team led by Houston Methodist addresses need for quick, easy tests to screen plasma donors. A new study released by Houston Methodist takes researchers a significant step…